Dr. Paul Bogner

Paul Bogner


Specializing In:

Diagnosis of skin tumors, including melanoma, carcinoma, lymphoma and sarcoma Diagnosis of rashes and inflammatory skin disease

Special Interests:

Biology of melanocytic and epithelial skin tumors

About Me


My focus is the laboratory diagnosis of skin disease, including skin cancer, rashes, and other conditions that can affect the skin. Proper pathologic diagnosis of the problem is often critical to getting the right treatment.

The Roswell Park Dermatopathology service reviews and diagnoses biopsies and other skin specimens from Roswell Park patients, patients in the WNY community and patients referred from elsewhere for a second diagnostic opinion.



Roswell Park Comprehensive Cancer Center
  • Associate Professor of Oncology
  • Director of Surgical Pathology
  • Head of Dermatopathology
  • Department of Pathology & Laboratory Medicine, Department of Dermatology
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
  • Staff Pathologist and Dermatopathologist
  • Department of Pathology & Anatomical Sciences


Education and Training:

  • BS - Molecular Biology and Genetics, University of Guelph, Guelph, Ontario, Canada
  • MD - School of Medicine and Biomedical Sciences, State University of New York at Buffalo


  • University of Michigan Health System, Ann Arbor, MI


  • Roswell Park Cancer Institute (Oncologic Surgical Pathology) Buffalo, NY
  • University of Michigan Health System (Dermatopathology) Ann Arbor, MI

Board Certification:

  • Anatomic Pathology, American Board of Pathology
  • Clinical Pathology, American Board of Pathology
  • Dermatopathology, American Board of Pathology

Professional Memberships:

  • American Society of Dermatopathology


  • Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, Demmy TL, Groman A, Reid M. Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis.Surgery 2012; 1523:397-402
  • Lugade AA, Bogner PN, Thanavala Y. Murine model of chronic respiratory inflammation. Advances in experimental medicine and biology 2011; 780 :125-141
  • Lugade AA, Vethanayagam RR, Nasirikenari M, Bogner PN, Segal BH, Thanavala Y. Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae. American journal of respiratory cell and molecular biology 2011; 453:557-565
  • Kitagawa KH, Bogner P, Zeitouni NC. Photodynamic Therapy with Methyl-Aminolevulinate for the Treatment of Double Extramammary Paget's Disease. Dermatologic surgery 2011; 377:1043-1046
  • Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AKP, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HD, O'Malley J, Patel JD, Ready N, Rudin CM, Williams Jr CC. Small cell lung cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2011; 910:1086-1113
  • Shabbir A, Loss L, Bogner P, Zeitouni NC. Squamous cell carcinoma developing from an epidermoid cyst of the ear. Dermatologic surgery 2011; 375:700-703
  • Nasirikenari M, Chandrasekaran EV, Matta KL, Segal BH, Bogner PN, Lugade AA, Thanavala Y, Lee JJ, Lau JTY. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. Journal of leukocyte biology 2010;873:457-466
  • Khoury T, Arshad A, Bogner P, Ramnath N, Zhang S, Chandrasekhar R, Wilding G, Alrawi S, Tan D.Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Chest 2009; 1361:220-228
  • Bogner PN, Patnaik SK, Pitoniak R, Kannisto E, Repasky E, Hylander B, Yendamuri S, Ramnath N. Lung cancer xenografting alters microRNA profile but not immunophenotype. Biochemical and biophysical research communications 2009; 3862:305-310
  • Patel AV, Bogner PN, Klippenstein D, Ramnath N. Malignant pleural mesothelioma after household exposure to asbestos. Journal of clinical oncology 2008; 2633:5480-5483
  • Ong ES, Alassas MA, Bogner PN, Bullard Dunn K, Chey WY, Gibbs JF. Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome. Journal of clinical oncology 2008; 2621:3641-3642
  • Kim JH, Bogner PN, Baek SH, Ramnath N, Liang P, Kim HR, Andrews C, Park YM. Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target. Clinical cancer research 2008; 148:2326-2333
  • Kim JH, Bogner PN, Ramnath N, Park Y, Yu J, Park YM. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clinical cancer research 2007; 1313:3875-3882
  • Park SY, Yu X, Ip C, Mohler JL, Bogner PN, Park YM. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer research 2007; 6719:9294-9303